Loading…

Shortening of the leucocytes’ telomeres length in T2DM independent of age and telomerase activity

Aims This study aimed to examine the role of plasma telomerase (TE), plasma insulin, patient’s age and disease duration in determination of the leucocytes’ telomeres length (LTL) in T2DM. Methods Blood samples from Kuwaiti patients with T2DM (110) and non-diabetic subjects (94) were analyzed by SYBR...

Full description

Saved in:
Bibliographic Details
Published in:Acta diabetologica 2020-11, Vol.57 (11), p.1287-1295
Main Authors: AlDehaini, Dhuha M. B., Al-Bustan, Suzanne A., Ali, Muhalab E., Malalla, Zainab Hasan Abdulla, Sater, Mai, Giha, Hayder A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims This study aimed to examine the role of plasma telomerase (TE), plasma insulin, patient’s age and disease duration in determination of the leucocytes’ telomeres length (LTL) in T2DM. Methods Blood samples from Kuwaiti patients with T2DM (110) and non-diabetic subjects (94) were analyzed by SYBR Green Quantitative PCR for estimation of the Absolute Human Telomere Length and by ELISA for estimation of the TE activity and insulin level. The body mass index (BMI) and HOMA-IR were calculated. Results The results revealed marked shortening of the LTL in T2DM compared with the non-diabetic subjects (6.068, 2.276–11.652 vs. 10.979, 6.495–23.402 kb), p  
ISSN:0940-5429
1432-5233
DOI:10.1007/s00592-020-01550-4